publication venue for
- EPIDEMIOLOGY AND NATURAL HISTORY OF HAEMOPHILUS INFLUENZAE INFECTIONS IN ADULTS WITH CYSTIC FIBROSIS 2020
- THE SPUTUM MICROBIOME AND ITS ASSOCIATION WITH INCIDENT MYCOBACTEROIDES (MYCOBACTERIUM) ABSCESSUS INFECTION IN ADULTS WITH CF 2020
- GENOMIC EPIDEMIOLOGY OF ESCHERICHIA COLI INFECTIONS IN ADULTS WITH CYSTIC FIBROSIS 2019
- IMPACT OF POTENTIATORS AND CORRECTORS ON GASTROINTESTONAL COMPLICATIONS AND THE MICROBIOME IN CYSTIC FIBROSIS PATIENTS 2019
- INHALED TOBRAMYCIN'S EFFECT ON THE RESPIRATORY MICROBIOME AND ASSOCIATION WITH CLINICAL RESPONSE IN ADULTS WITH CYSTIC FIBROSIS 2019
- EPIDEMIOLOGY AND IMPACT OF HAEMOPHILUS INFLUENZAE AIRWAYS INFECTIONS IN ADULTS WITH CYSTIC FIBROSIS 2018
- THE EFFECTS OF AZITHROMYCIN ON THE CYSTIC FIBROSIS MICROBIOME 2018
- CFTR MODULATOR GUIDELINES 2017
- DISTRIBUTION AND CLINICAL IMPACT OF CLONAL PSEUDOMONAS AERUGINOSA INFECTION IN THE CANADIAN CYSTIC FIBROSIS POPULATION 2017
- EPIDEMIOLOGY OF STENOTROPHOMONAS MALTOPHILIA INFECTIONS IN ADULTS WITH CYSTIC FIBROSIS (CF): A 30-YEAR SINGLE-CENTRE STUDY 2017
- MARITIME CYSTIC FIBROSIS NEWBORN SCREENING PROGRAM: AN UPDATE 2017
- PATTERNS OF PSEUDOMONAS AERUGINOSA LOWER AIRWAYS INFECTIONS AND CLINICAL OUTCOMES IN NON-CYSTIC FIBROSIS BRONCHIECTASIS 2017
- SPUTUM MICROBIOTA PREDICTS FUTURE CLINICAL OUTCOMES IN CYSTIC FIBROSIS: A COHORT STUDY 2017
- THE SWEAT METABOLOME OF SCREEN-POSITIVE CYSTIC FIBROSIS INFANTS: REVEALING MECHANISMS BEYOND IMPAIRED CHLORIDE TRANSPORT 2017
- DOES INHALED AZTREONAM LYSINE (AZLI) IMPACT THE CYSTIC FIBROSIS LUNG MICROBIOME? 2016
- EFFECT OF FREEZING SPUTUM ON PSEUDOMONAS AERUGINOSA (PA) POPULATION HETEROGENEITY 2016
- EPIDEMIC PSEUDOMONAS AERUGINOSA: A DRIVING FORCE IN THE CYSTIC FIBROSIS (CF) MICROBIOME? 2016
- METABOLOMICS FOR DISCOVERY OF CYSTIC FIBROSIS-SPECIFIC MARKERS IN AFFECTED NEWBORNS: EARLY DETECTION WITHOUT WIDESPREAD GENETIC TESTING 2016
- THE EVOLVING CYSTIC FIBROSIS (CF) MICROBIOME: A LONGITUDINAL COHORT STUDY 2016
- NUTRITIONAL STATUS, NUTRITIONAL MONITORING AND FOOD SECURITY IN CHILDREN BELOW 18 YEARS, DIAGNOSED WITH CYSTIC FIBROSIS IN ANTIOQUIA COLOMBIA 2016
- Changes in multiple breath washout measures after raised volume rapid thoracoabdominal compression maneuvers in infants. 2016
- CHANGES IN THE STRUCTURE OF THE CYSTIC FIBROSIS MICROBIOME THROUGH TIME: A COHORT STUDY 2015
- CULTURE-ENRICHED METAGENOMIC SEQUENCING OF THE CYSTIC FIBROSIS LUNG MICROBIOTA PROVIDES A MORE THOROUGH UNDERSTANDING OF MICROBIAL PROCESSES DURING PULMONARY EXACERBATION 2015
- DEVELOPMENT AND VALIDATION OF A PCR ASSAY TO DETECT THE PRAIRIE EPIDEMIC STRAIN (PES) OF PSEUDOMONAS AERUGINOSA 2015
- DO INHALED ANTIBIOTICS IMPROVE LUNG FUNCTION THROUGH AN EFFECT ON THE CYSTIC FIBROSIS (CF) MICROBIOME? 2015
- LONGITUDINAL SAMPLING OF PATIENTS WITH CYSTIC FIBROSIS INDICATES CHANGES IN THE MICROBIAL COMMUNITY IN THE DAYS PRIOR TO ONSET OF PULMONARY EXACERBATION 2015
- PROGRESSION AND VARIABILITY OF LCI IN PRESCHOOL CHILDREN WITH CYSTIC FIBROSIS 2015
- UTILITY OF THE LUNG CLEARANCE INDEX TO MONITOR PULMONARY EXACERBATIONS IN YOUNG CHILDREN WITH CYSTIC FIBROSIS 2015
- DEFINING THE VARIABILITY OF THE LUNG CLEARANCE INDEX IN HEALTH AND DISEASE FOR PRESCHOOL CHILDREN 2014
- LUNG FUNCTION OUTCOMES IN YOUNG CHILDREN WITH CF 2014
- PREDICTORS OF RESPONSE TO ANTIBIOTIC TREATMENT OF PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS 2014
- RANDOMIZED CONTROLLED TRIAL OF BIOFILM ANTIMICROBIAL SUSCEPTIBILITY TESTING IN PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTION 2014
- REDUCTION IN P. AERUGINOSA SPUTUM DENSITY DURING A PULMONARY EXACERBATION IN CYSTIC FIBROSIS DOES NOT PREDICT CLINICAL RESPONSE 2014
- A COMPARISON OF MULTIPLE BREATH WASHOUT OUTCOMES IN PRESCHOOL CHILDREN: MASS SPECTROMETRY VERSUS NITROGEN WASHOUT 2013
- HIGH-THROUGHPUT SCREENING FOR GROWTH INHIBITORS OF BURKHOLDERIA CENOCEPACIA 2013
- DEFINING CF BASED ON GENOTYPE: A WORLDWIDE PERSPECTIVE 2012
- EFFECT OF HYPERTONIC SALINE ON LUNG CLEARANCE INDEX IN INFANTS AND PRESCHOOL CHILDREN WITH CF: A PILOT STUDY 2012
- MECONIUM ILEUS PREVALENCE SCORE AS NEW PHENOTYPIC MARKER FOR THE SEVERITY OF CFTR MUTATIONS 2012
- MULTIPLE BREATH WASHOUT PARAMETERS FOR INTERVENTIONAL STUDIES IN CF: MOMENT RATIOS COMPARED TO LCI 2012
- NITROGEN MULTIPLE BREATH WASHOUT IS MORE SENSITIVE THAN SF6 BASED LCI MEASUREMENTS AT DETECTING LUNG ABNORMALITIES IN CHILDREN WITH CF 2012
- VALIDATION OF A NITROGEN (N-2) BASED MULTIPLE BREATH WASHOUT TECHNOLOGY IN HEALTHY CHILDREN AND CHILDREN WITH CYSTIC FIBROSIS 2012
- EXPLORING THE STREPTOCOCCUS ANTIBIOTIC RESISTOME IN ADULT CYSTIC FIBROSIS PATIENTS 2011
- IMPACT OF BRONCHIECTASIS AND TRAPPED AIR ON QUALITY OF LIFE IN CYSTIC FIBROSIS LUNG DISEASE - A CT AND MRI COMPARISON 2011
- MECHANISMS OF ANTIMICROBIAL RESISTANCE IN CYSTIC FIBROSIS AIRWAY ISOLATES OF THE STREPTOCOCCUS MILLERI GROUP 2011
- SPINK1 MUTATION N34S INCREASES RISK OF PANCREATITIS IN PATIENTS WITH CF AND CFTR-RELATED DISORDERS 2011
- SWEATING THE SMALL STUFF: A QUALITY ASSURANCE AUDIT OF SWEAT CHLORIDE TESTING FOR CYSTIC FIBROSIS NEWBORN SCREENING FOLLOW-UP 2011
- TRANSLATING RESEARCH INTO PRACTICE: IMPLEMENTING A DECISION AID FOR ADULT CYSTIC FIBROSIS PATIENTS 2011
- ASSESSING DISEASE LIABILITY OF MISSENSE CFTR MUTATIONS USING DIFFERING PERCENTAGES OF WILD-TYPE FUNCTION 2010
- CONSTITUENTS OF THE APICAL PLASMA MEMBRANE MAY CONTRIBUTE TO MECONIUM ILEUS 2010
- HIGH PREVALENCE OF CYSTIC FIBROSIS IN PATIENTS WITH IDIOPATHIC CHRONIC SINOPULMONARY DISEASE 2010
- PHYSICAL ACTIVITY AND LUNG HEALTH IN PATIENTS WITH CYSTIC FIBROSIS: A 7-YEAR STUDY 2010
- THE CYSTIC FIBROSIS LUNG MICROBIOME EXPOSES NOVEL MEMBERS OF THE GENUS STREPTOCOCCUS 2010
- THE EFFECT OF DORNASE ALFA ON VENTILATION INHOMOGENEITY IN PATIENTS WITH CYSTIC FIBROSIS 2010
- TOLL-LIKE RECEPTOR 5 AS AN ANTI-INFLAMMATORY TARGET AND MODIFIER GENE IN CYSTIC FIBROSIS 2010
- CHARACTERIZATION OF STREPTOCOCCUS MILLERI ISOLATES FROM ADULT CYSTIC FIBROSIS PATIENTS 2009
- INCREASED RISK OF PANCREATITIS ASSOCIATED WITH MILD CFTR MUTATIONS 2009
- INHALED HYPERTONIC SALINE (7%) IMPROVES LCI IN PAEDIATRIC CF PATIENTS WITH NORMAL LUNG FUNCTION 2009
- REAL-TIME PCR ASSAYS FOR DETECTION OF THE STREPTOCOCCUS MILLERI GROUP FROM CF CLINICAL SPECIMENS USING TARGETS FOR CPN60 AND 16S RRNA GENES 2009
- THE CULTURED MICROBIOME OF CYSTIC FIBROSIS AIRWAYS 2009
- WHICH MEASURES OF PHYSICAL FITNESS ARE USEFUL IN CHIDREN WITH CF? 2009
- WHOLE GENOME SEQUENCING AND COMPARATIVE GENOMIC ANALYSIS OF THE STREPTOCOCCUS MILLERI GROUP 2009
- A 6 megabase region on the long arm of chromosome 5 displays linkage to cross-sectional and longitudinal measures of cystic fibrosis lung disease severity 2007
- Development of a solid media for the selective isolation of Streptococcus milleri from cystic fibrosis (CF) sputum 2007
- Genetic modifiers of severe liver disease in cystic fibrosis: A replication study 2007
- Polymicrobial interactions in CF: Synergies and antagonisms in host response 2007
- Reliability and validity of the Habitual Activity Estimation Scale (HAES) in patients with cystic fibrosis 2007
- Inhaled mannitol identifies methacholine-responsive children with active asthma 2000
- Lung biopsy in infants with severe bronchopulmonary dysplasia. 58:2068-2075. 2023
- Chronic tracheostomy care of ventilator‐dependent and ‐independent children: Clinical practice patterns of pediatric respirologists in a publicly funded (Canadian) healthcare system. 58:140-151. 2023
- Systematic review and cost‐utility of high flow nasal cannula versus continuous positive airway pressure in children with acute severe or moderate bronchiolitis in Colombia. 57:3111-3118. 2022
- Diagnostic accuracy of point‐of‐care ultrasound compared to standard‐of‐care methods for endotracheal tube placement in neonates. 57:1744-1750. 2022
- Efficiency of budesonide delivery via a mesh nebulizer in an in‐vitro neonatal ventilator model. 55:2283-2288. 2020
- Test for respiratory and asthma control in preschool kids in the emergency department as a predictor of wheezing exacerbations. 55:338-345. 2020
- How to use noninvasive positive airway pressure device data reports to guide clinical care. 55:58-67. 2020
- Patterns of health care use related to respiratory conditions in early life: A birth cohort study with linked administrative data. 54:1267-1276. 2019
- High continuous positive airway pressure in neonates: A physiological study. 54:1039-1044. 2019
- Prolonged respiratory support of any type impacts outcomes of extremely low birth weight infants. 53:1447-1455. 2018
- Improved growth and developmental activity post tracheostomy in preterm infants with severe BPD. 53:1237-1244. 2018
- Reference equations for the interpretation of forced expiratory and plethysmographic measurements in infants. 53:907-916. 2018
- Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants. 53:605-612. 2018
- Caregiver knowledge and skills to safely care for pediatric tracheostomy ventilation at home. 52:1610-1615. 2017
- What families have in the emergency tracheostomy kits: Identifying gaps to improve patient safety. 52:1605-1609. 2017
- Misdiagnosis of asthma in schoolchildren. 52:293-302. 2017
- Changes in multiple breath washout measures after raised volume rapid thoracoabdominal compression maneuvers in infants. 51:183-188. 2016
- Anti‐gastroesophageal reflux surgery in infants with severe bronchopulmonary dysplasia. 50:584-587. 2015
- Physiological correlates of pulmonary function in children with cystic fibrosis. 49:878-884. 2014
- The prevalence of asthma in Canadian children of South Asian descent. 49:43-48. 2014
- Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors. 47:421-428. 2012
- A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies. 46:857-869. 2011
- The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis. 46:554-558. 2011
- Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis. 46:385-392. 2011
- Isolated central sleep apnea in type I Chiari malformation: improvement after surgery.. 45:1141-1144. 2010
- Predictors of major intervention in infants with bronchiolitis. 44:358-363. 2009
- Assessment of body composition in pediatric patients with cystic fibrosis. 43:1025-1032. 2008
- The Streptococcus milleri group—An unrecognized cause of disease in cystic fibrosis: A case series and literature review. 43:490-497. 2008
- Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis. 43:345-353. 2008
- Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis. 42:471-476. 2007
- Internet and written respiratory questionnaires yield equivalent results for adolescents. 42:357-361. 2007
- New measure of parental asthma management for school-age children. 40:241-250. 2005
- Limitations of electronic compensation for measuring plethysmographic airway resistance in infants. 40:45-52. 2005
- Sweat‐testing: A review of current technical requirements. 39:507-511. 2005
- Comparison of spirometric reference values. 37:515-522. 2004
- Breastfeeding and asthma: Appraising the controversy—A rebuttal. 36:366-368. 2003
- Validation of shuttle tests in children with cystic fibrosis. 35:133-138. 2003
- Outcome in adulthood of asymptomatic airway hyperresponsiveness in childhood: A longitudinal population study. 34:164-171. 2002
- Randomized controlled study of in‐hospital exercise training programs in children with cystic fibrosis. 33:194-200. 2002
- Therapeutic equivalence of three metered‐dose inhalers containing salbutamol (Albuterol) in protecting against methacholine‐induced bronchoconstriction in children with asthma. 32:447-452. 2001
- Bronchoscopic instillation of surfactant in acute respiratory distress syndrome. 31:317-320. 2001
- To the editor: Are long‐acting beta‐agonists the “winning team” in childhood asthma?. 31:327-327. 2001
- Limited agreement between written and video asthma symptom questionnaires. 30:307-312. 2000
- Association between parental perception of children's vulnerability to illness and management of children's asthma. 29:88-93. 2000
- Aerosol delivery to children: What to use, how to choose. 27:79-82. 1999
- Rationale for spacer use in children. 23:184-185. 1997
- How important is quality of life in pediatric asthma?. 24:17-21. 1997
- Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. 21:301-309. 1996
- Risk factors for airway hyperresponsiveness in childhood asthma. 19:42-43. 1995
- Resistive and elastic unloading to assist spontaneous breathing does not change functional residual capacity. 16:170-176. 1993
- Correspondence. 13:128-129. 1992
- ON BIRTH-WEIGHT AND COMPLIANCE OF THE RESPIRATORY SYSTEM AS PREDICTORS OF OUTCOME IN INFANTS WITH RESPIRATORY-FAILURE - REPLY. 13:129-129. 1992
- The effects of airway hyperresponsiveness, wheezing, and atopy on longitudinal pulmonary function in children: A 6‐year follow‐up study. 13:78-85. 1992
- Birthweight, early passive respiratory system mechanics, and ventilator requirements as predictors of outcome in premature infants with respiratory failure. 10:195-198. 1991
- Reliable salbutamol administration in 6‐ to 36‐month‐old children by means of a metered dose inhaler and aerochamber with mask. 6:263-267. 1989